These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5917058)

  • 1. [Periodic treatment of chronic nephropathies with an artificial kidney].
    Bangoni AG
    Minerva Urol; 1966; 18(2):74-5. PubMed ID: 5917058
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of chronic hyperazotemic nephropathies with periodic hemodialysis].
    Galanti G
    Minerva Med; 1967 Dec; 58(97):4323-5. PubMed ID: 6082385
    [No Abstract]   [Full Text] [Related]  

  • 3. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further observations on the ophthalmoscopic picture during chronic renal insufficiency treated with periodic hemodialysis].
    Calogero R; Revoltella R; Ancona G; Bruschi E; Galanti G; Dalla Rosa C; Confortini P
    Minerva Med; 1967 Jun; 58(45):2110-3. PubMed ID: 6028370
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polygraphic studies before and after strophanthin therapy in subjects undergoing periodic dialytic treatment].
    Pasqualicchio A; Pasoli CA; Franzoni A; Ancona G; Bruschi E; Gianfranceschi G
    Fracastoro; 1969; 62(1):21-5. PubMed ID: 5402907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Periodic treatment with the artificial kidney of chronic kidney diseases. Notes on technic].
    Confortini P; Galanti G; Ancona G; Bruschi E; Dalla Rosa C; Cora D
    Minerva Med; 1965 Nov; 56(94):4053-78. PubMed ID: 5846627
    [No Abstract]   [Full Text] [Related]  

  • 8. [Duration and complications of permanent shunts for extracorporeal hemodialysis].
    Ancona G; Galanti G; Bruschi E; Dalla Rosa C; Confortini P
    Minerva Med; 1967 Jun; 58(45):2105-9. PubMed ID: 6028368
    [No Abstract]   [Full Text] [Related]  

  • 9. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
    Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
    G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
    [No Abstract]   [Full Text] [Related]  

  • 10. The present use of the artificial kidney.
    Pinck BD
    J Med Soc N J; 1968 Aug; 65(8):455-9. PubMed ID: 5243431
    [No Abstract]   [Full Text] [Related]  

  • 11. [Water and salt metabolism in chronic uremigenic nephropathies].
    Mioni G; Cristinelli L; Messa PG; Montanaro D
    G Clin Med; 1980 May; 61(5):332-41. PubMed ID: 7450354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dialysis treatment in chronic renal insufficiency in the USA and Europe-a short survey].
    Alwall N
    Nord Med; 1966 May; 75(18):501-2. PubMed ID: 5909154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activities of the nephropathology and extrarenal dialysis department (19 October 1964--19 October 1965)].
    Della Grazia M; Pisani E; Ponticelli C; Redaelli B; Brancaccio D; Palleni R; Graziani G; Imbasciati E
    Minerva Med; 1967 Jun; 58(45):2086-93. PubMed ID: 6028362
    [No Abstract]   [Full Text] [Related]  

  • 14. Residual renal function and dialysis modality: is it really beneficial to preserve residual renal function in dialysis patients?
    Canaud B; Chenine L; Leray-Moragués H; Wiesen H; Tetta C
    Nephrology (Carlton); 2006 Aug; 11(4):292-6. PubMed ID: 16889567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problem of renal diseases in Puerto Rico and its treatment with dialysis and transplantation].
    Ramírez-González RE
    Bol Asoc Med P R; 1980 Feb; 72(2):45-8. PubMed ID: 6992792
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney disease and cardiovascular disease: implications of dyslipidemia.
    Keane WF; Lyle PA
    Cardiol Clin; 2005 Aug; 23(3):363-72. PubMed ID: 16084284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Artificial dialyzer therapy].
    Ishii J; Takagaki S; Kaneshiro Y; Tsukioka T; Ogasawara M
    Shujutsu; 1966 Apr; 20(4):305-13. PubMed ID: 5960569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Active treatment of renal disease in Finland].
    Stenman S; Grönhagen-Riska C
    Duodecim; 1995; 111(15):1497-504. PubMed ID: 9244706
    [No Abstract]   [Full Text] [Related]  

  • 19. Kidney camp.
    Stephenson T; Jakubawski JA
    J Nephrol Nurs; 1985; 2(2):46-7. PubMed ID: 3845976
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of plasmatic cholinesterase in the course of hemodialysis].
    Cortesi S; Vettore L; Ancona G; Galanti G; De Sandre G
    Minerva Med; 1967 Jun; 58(45):2103-5. PubMed ID: 6028367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.